Results 111 to 120 of about 24,887 (213)

Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas. [PDF]

, 2015
International audienceTreatment for recurrent and aggressive meningiomas remains an unmet medical need in neuro-oncology, and chemotherapy exhibits limited clinical activity, if any.
Mohamed, Amira, Lisbonis, Christophe, Chinot, Olivier, Roche, Pierre-Hugues, Metellus, Philippe, Defilles, Céline, Figarella-Branger, Dominique, Adetchessi, Tarek, Fuentes, Stéphane, Barlier, Anne, A., Enjalbert, Alain, Graillon, Thomas, Germanetti, Anne-Laure, Dufour, Henry   +13 more
core  

Differential Effects of Somatostatin on TNF Receptors and Apoptosis in Hepatocellular Carcinoma Cell Lines

Gastroenterology Insights
The anti-tumoral activity of somatostatin has been demonstrated in both animal experiments and human tumors. Clinical trials have reported conflicting results.
Maria Georgiadou, George Notas, Ioannis Tsomidis, Argyro Voumbouraki, Ioannis Drygiannakis, George Emmanouil, Elias Kouroumalis   +6 more
doaj   +1 more source

Refractory Thrombocytopenia Responds to Octreotide Treatment in a Case of Evans Syndrome with Gastric Neuroendocrine Tumor

Case Reports in Hematology, 2013
A 37-year-old woman with history of Evans Syndrome with poor response to high-dose corticoid treatment presented to the emergency department with gastrointestinal and vaginal bleeding.
Kocfa Chung-Delgado, Alejandro Revilla-Montag, Sonia Guillén-Bravo, Hugo Ríos-Díaz, José C. Alva-Muñoz   +4 more
doaj   +1 more source

Five Advances in the Last 50 Years That Have Impacted Endocrine Surgery

World Journal of Surgery, Volume 50, Issue 8, Page 2071-2076, August 2026.
Matilda Anneback, Priya H. Dedhia, Aimee Di Marco, Els Nieveen van Dijkum, Julie A. Miller, Janice L. Pasieka   +5 more
wiley   +1 more source

Pancreatic Cancer—Advances in the Last 50 Years

World Journal of Surgery, Volume 50, Issue 8, Page 2106-2115, August 2026.
S. George Barreto, Anirban Maitra, Eileen M. O'Reilly, Dushyant Sahani, Richard Zheng, Charles J. Yeo   +5 more
wiley   +1 more source

Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide [PDF]

, 1995
Recently, we developed a technique that allows the in vivo visualization in man of somatostatin receptor-positive neuroendocrine tumors after i.v.
Waaijers, M. (Marlijn), Zuyderwijk, J., Breeman, W.A.P. (Wouter), Koetsveld, P.M. (Peter) van, Lamberts, S.W.J. (Steven), Hofland, L.J. (Leo)   +5 more
core  

Octreotide improves human lymphatic fluid transport a translational trial [PDF]

OBJECTIVESChylothorax is a complex condition and many different pharmacological agents have been tried as treatment. Octreotide is used off-label to treat chylothorax, but the efficacy of octreotide remains unclear.
Skov, Frederik, Christensen, Mikkel Bring, Thorup, Lene, Hjortdal, Vibeke Elisabeth, Holm-Weber, Thomas, Mohanakumar, Sheyanth, Riis, Troels, Sonne, David Peick, Jensen, Per Bo, Bødtkjer, Donna Briggs   +9 more
core   +1 more source

Somatostatin receptor subtypes, octreotide scintigraphy, and clinical response to octreotide treatment in patients with neuroendocrine tumors [PDF]

, 1998
Several types of neuroendocrine tumor express high numbers of somatostatin receptors (sstr). We have compared the expression of sstr subtypes with the outcome of octreotide scintigraphy in patients with carcinoids and medullary thyroid carcinoma (MTC) in
Nilsson, Ola,, Wängberg, Bo,, Forssell-Aronsson, Eva,, Ahlman, Håkan,, Fjälling, M, Tisell, Lars-Eric,, Kölby, Lars,   +6 more
core  

18F-AlF-NOTA-octreotide PET/CT and 3D printing technology for precision diagnosis and treatment of phosphaturic mesenchymal tumors in patients with tumor-induced osteomalacia: two case reports

Frontiers in Endocrinology
ObjectiveThis study aims to report the application of 18F-AlF-NOTA-Octreotide PET/CT and 3D printing technology in the diagnosis and treatment of phosphaturic mesenchymal tumors (PMT) in patients with tumor-induced osteomalacia (TIO).Case presentationA ...
Gang Zhao, Lijuan Guan, Yongqiang Zhang, Xingzhen Shi, Wenming Luo, Maiqing Yang, Qi Wang, Zhen Liu, Yongqiang Liu, Xiaolei Ding, Jie Zhao   +10 more
doaj   +1 more source

Comparison of 177Lu-octreotate and 177Lu-octreotide for treatment in human neuroblastoma-bearing mice

Heliyon
Background: Patients with high-risk neuroblastoma (NB) have a 5-year event-free survival of less than 50 %, and novel and improved treatment options are needed. Radiolabeled somatostatin analogs (SSTAs) could be a treatment option.
A. Romiani, K. Simonsson, D. Pettersson, A. Al-Awar, N. Rassol, H. Bakr, D.E. Lind, G. Umapathy, J. Spetz, R.H. Palmer, B. Hallberg, K. Helou, E. Forssell-Aronsson   +12 more
doaj   +1 more source